IVIG Dilution and Infusion Rate
IVIG should NOT be diluted with intravenous fluids and must be infused through a separate IV line at an initial rate of 0.01 mL/kg/min (0.5 mg/kg/min), gradually increasing to a maximum of 0.10 mL/kg/min (5 mg/kg/min) if tolerated. 1
Preparation Guidelines
Do not dilute IVIG products. The FDA-approved drug labels explicitly state that IVIG formulations like Flebogamma 5% DIF should not be diluted with intravenous fluids 1. The product comes ready to use at its manufactured concentration (typically 5% or 10% solutions containing 50-100 mg/mL of IgG).
Key Preparation Steps:
- Inspect vials visually for particulate matter and turbidity before use—discard if present 1
- Multiple vials may be pooled into an empty sterile container using aseptic technique for large doses 1
- Never mix IVIG products from different manufacturers or formulations 1
- Infuse through a separate, dedicated IV line—do not add other medications or fluids to the infusion 1
- Use promptly after opening; discard partially used vials as the solution contains no preservative 1
Infusion Rate Protocol
Standard Rate Escalation:
Initial rate: 0.01 mL/kg/min (0.5 mg/kg/min) 1
Rate advancement: If well-tolerated after the first 30 minutes, gradually increase the rate 1
Maximum rate: 0.10 mL/kg/min (5 mg/kg/min) 1
Clinical Context for Rate Adjustments:
Recent evidence suggests faster escalation protocols may be safe in selected patients. A 15-minute rate escalation protocol with 10% IVIG formulations reduced infusion times without increasing adverse events 2. In CIDP patients, rates up to 0.14 mL/kg/min were safely tolerated 3. However, the FDA-approved maximum remains 0.10 mL/kg/min for standard practice 1.
High-Risk Populations Requiring Slower Rates:
Administer IVIG at the minimum rate practicable in patients with 1:
- Pre-existing renal insufficiency (any degree)
- Age >65 years
- Diabetes mellitus
- Volume depletion
- Sepsis
- Paraproteinemia
- Concurrent nephrotoxic drug use
Cardiac Considerations:
Before IVIG administration, assess cardiac function and fluid status 4. In patients with depressed cardiac function:
- Consider dividing the dose (1 g/kg daily over 2 days instead of 2 g/kg as a single dose) 4
- Provide close monitoring and diuretics during administration 4
- Slow the infusion rate further if needed
Monitoring During Infusion
Monitor vital signs continuously throughout the infusion 1. If adverse reactions occur:
- Immediately slow or stop the infusion 1
- If symptoms subside promptly, resume at a lower rate that is comfortable for the patient 1
- Common mild reactions (headache, flushing, fever, chills) occur in 24-36% of infusions and can often be managed by slowing the rate 5
Common Pitfalls to Avoid
Never dilute IVIG—this is explicitly contraindicated and may affect product stability and efficacy 1
Do not use shared IV lines—IVIG must have a dedicated line to prevent incompatibilities 1
Avoid rapid rate escalation in high-risk patients—this increases risk of renal failure, thrombosis, and hemodynamic instability 1, 5
Do not administer to volume-depleted patients—ensure adequate hydration before starting infusion to prevent renal complications 1, 5
Monitor renal function—check BUN and creatinine before initial infusion and periodically thereafter, especially in at-risk patients 1